Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.

PHASE3CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Vortioxetine

Encapsulated vortioxetine immediate-release tablets.

DRUG

Placebo

Vortioxetine placebo-matching capsules

Trial Locations (38)

Unknown

Tallinn

Viljandi

Bad Saarow

Berlin

Bochum

Hüttenberg

Rodgau

Schwerin

Wiesbaden

Liepāja

Riga

Sigulda

Kaunas

Palanga

Vilnius

Bialystok

Gdynia

Gorlice

Leszno

Skórzewo

Torun

Tuszyn

Bucharest

Oradea

Kazan'

Lipetsk

Moscow

Rostov-on-Don

Saint Petersburg

Samara

Smolensk

Stavropol

Yekaterinburg

Dnipro

Kharkiv

Liev

Luhansk

Simferopol

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Takeda

INDUSTRY